Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mineralys Therapeutics, Inc. - Common Stock
(NQ:
MLYS
)
12.34
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12
Open
12.34
Bid (Size)
4.940 (2)
Ask (Size)
19.74 (2)
Prev. Close
12.34
Today's Range
12.34 - 12.34
52wk Range
7.864 - 16.91
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Earnings Scheduled For November 11, 2024
November 11, 2024
Via
Benzinga
Insights into Mineralys Therapeutics's Upcoming Earnings
November 08, 2024
Via
Benzinga
Performance
YTD
+42.17%
+42.17%
1 Month
-1.20%
-1.20%
3 Month
+7.77%
+7.77%
6 Month
-2.30%
-2.30%
1 Year
+51.23%
+51.23%
More News
Read More
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!
September 20, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Mineralys Therapeutics Earnings Preview
March 20, 2024
Via
Benzinga
Where Mineralys Therapeutics Stands With Analysts
May 16, 2023
Via
Benzinga
Where Mineralys Therapeutics Stands With Analysts
March 16, 2023
Via
Benzinga
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!
September 12, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
September 09, 2024
From
Schall Law
Via
GlobeNewswire
MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q2 2024
August 13, 2024
Via
InvestorPlace
MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
MLYS Stock Earnings: Mineralys Therapeutics Beats EPS for Q4 2023
March 21, 2024
Via
InvestorPlace
Earnings Scheduled For March 21, 2024
March 21, 2024
Via
Benzinga
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 08, 2024
Via
Benzinga
Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday
February 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Via
Benzinga
Praxis Bioresearch Expands its Board of Directors with Appointment of Adam Levy
September 19, 2023
From
Praxis Bioresearch, Inc.
Via
GlobeNewswire
$5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying
September 11, 2023
Via
Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
July 17, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying
February 17, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 14, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 13, 2023
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.